MENU
CGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cognition Therapeutics (CGTX) Ownership - Who owns Cognition Therapeutics?
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina... Show more
Profile
Industry
N/A
Address
2500 Westchester Avenue
Phone
+1 412 481-2210
Employees
28
Web
https://www.cogrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
18.11M
P/E Ratio
N/A
Total Cash
16.43M
Projected Growth
N/A
Total Debt
635K
Revenue
N/A
Risk (Beta)
0.99
Dividend Yield
N/A
Total Cash/Share
0.26
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CGTX
Capitalization
18.1M
P/E Ratio
N/A
Risk (Beta)
0.99
Dividend Yield
N/A
Total Cash
16.4M
Total Cash/Share
0.26
Total Debt
635K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
12.3M
P/B Ratio
1.48
Cash Flow
N/A
Earnings
-0.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
62K
Current Ratio
2.09
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-33.03M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-106.81
Shares Held By Institutions
8.19M
Shares Outstanding - Current
62M
Total Liabilities
11.2M
Total Volume MTD
N/A
Value
1
Gain YTD
-58.349
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2500 Westchester Avenue
Phone
+1 412 481-2210
Employees
28
Web
https://www.cogrx.com